The studies could be useful for designing selective agonists/antagonists for various serotonin receptors (5HT1A, 5HT2A, 5HT2B, 5HT2C, and 5HT7) involved in detrimental disorders such as addiction and schizophrenia in the future. This evidence concerns the gene HTR1A and schizophrenia.